A new injection to prevent HIV, rather than pills, is a game changer, scientists say
A new injection to prevent HIV, rather than pills, is a game changer, scientists say Enlarge this image toggle caption ViiV Healthcare ViiV Healthcare A long-awaited development to help stop the spread of HIV and AIDS was approved by the U.S. Food and Drug Administration this week, and scientists are calling it a game-changer. The drug, called Apretude but also known as cabotegravir, is an injection that has proven to be significantly more effective at reducing the risk of sexually-acquired HIV. Sponsor Message "This new medication, cabotegravir, is a game changer," Kenneth Mayer, medical research director at Fenway Health in Boston, one of the sites where it was tested in clinical trials, told NPR. "This injection, given every two months, will be critical to addressing the HIV epidemic in the U.S., including helping high-risk individuals and certain groups where adherence to daily medication has been a major challenge or not a realistic option," Dr. Debra Birnkrant, director of the Division of Antivirals at the FDA, said in a statement.










HIV-negative people who are at risk of an infection should take PrEP, experts say












Discover Related

In South Africa, needle exchange programme for drug users feels effects of Trump's aid cuts

This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout

HIV prevention programme extended to March 2026, says health minister

Conflicting signals from Trump could disrupt HIV meds. What's the impact?

Experts warn against DoxyPEP STI prevention over antibiotic resistance

Ready to quit vaping in the new year? A new study uncovers the best ways

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

Global HIV rates drop by 20 percent Challenges to end AIDS by 2030 remain

'Remarkable global progress': HIV cases and deaths declining

Effective HIV Prevention Methods Everyone Should Know

New ‘game changer’ stop smoking pill to be given to thousands on NHS

UK NHS rolls out a new 'stop-smoking' pill: Could this be the game-changer smokers need?

Pharmaceutical giant GSK vows more cutting-edge HIV treatment

‘Game changer’ take home blood cancer drug to be offered to hundreds of NHS patients

US pediatricians reverse decades-old advice against HIV-positive mothers breastfeeding

International Condom Day 2024: Date, history, significance

Newer treatment options show promising results in HIV management

World Aids Day 2023: Causes, Transmission, Treatment & Prevention Of AIDS

For 20 years, this AIDS relief plan enjoyed broad US support. What changed?
